Franco Semprini
University of Bologna
34 Papers
200 Citations
Franco Semprini is an academic researcher from University of Bologna. The author has contributed to research in topics: Medicine & Myocardial infarction. The author has an hindex of 11, co-authored 28 publications.
Chat about Author
Papers
Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction
Giovanni Melandri,Fabio Vagnarelli,Daniela Calabrese,Franco Semprini,Samuele Nanni,Angelo Branzi +5 more
TL;DR: The small available randomized studies and international clinical registries suggest that pre-hospital TNKase is as effective as primary angioplasty, thus laying the foundations for a new fibrinolytic,TNKase-based strategy as the backbone of reperfusion in acute myocardial infarction.
63
Benefit of adding low molecular weight heparin to the conventional treatment of stable angina pectoris. A double-blind, randomized, placebo-controlled trial.
Giovanni Melandri,Franco Semprini,Vittorio Cervi,N Candiotti,Ernesto Palazzini,Angelo Branzi,Bruno Magnani +6 more
TL;DR: Patients with stable angina pectoris may be treated with Parnaparin in addition to aspirin and conventional antianginal medication, and side effects are negligible, and compliance is excellent.
50
Enhanced thrombolytic efficacy and reduction of infarct size by simultaneous infusion of streptokinase and heparin.
Giovanni Melandri,Angelo Branzi,Franco Semprini,Vittorio Cervi,Nazzareno Galiè,Bruno Magnani +5 more
TL;DR: In this article, the velocity of reperfusion and degree of myocardial damage were studied when heparin was infused during rather than after streptokinase infusion, and the serum concentration of creatine kinase was measured every 2 hours.
31
Impact of high-sensitivity Troponin T on hospital admission, resources utilization, and outcomes.
Anna Corsini,Fabio Vagnarelli,Giulia Bugani,Maria Letizia Bacchi Reggiani,Franco Semprini,Samuele Nanni,Laura Cinti,Giulia Norscini,Antonio Vannini,Elisabetta Beltrandi,Mario Cavazza,Angelo Branzi,Claudio Rapezzi,Giovanni Melandri +13 more
TL;DR: The epidemiological, clinical and prognostic impact of introducing hs-cTnT in the everyday clinical practice of an Emergency Department did not observe overdiagnosis and overtreatment issues in presenters with suspected ACS, despite the increase in the number of patients presenting with abnormal troponin levels.
23
On the value of the activated clotting time for monitoring heparin therapy in acute coronary syndromes.
Giovanni Melandri,Angelo Branzi,Anna Maria Traini,Franco Semprini,Vittorio Cervi,Bruno Magnani +5 more
TL;DR: Heparin therapy may be monitored at the bedside with new portable machines measuring the activated clotting time (ACT) of the whole blood and the activated partial thromboplastin time (aPTT) for monitoring heparin therapy in the coronary care unit.
22